Department of Otolaryngology and Laryngological Oncology with Clinical Department of Cranio-Maxillofacial Surgery, Military Institute of Medicine - National Research Institute, Warsaw.
Clinical Department of Hyperbaric Medicine, Military Institute of Medicine - National Research Institute, Warsaw.
Otolaryngol Pol. 2023 Apr 17;77(3):7-11. doi: 10.5604/01.3001.0016.3301.
<b>Introduction:</b> The COVID-19 pandemic constituted a significant challenge for healthcare systems. Epidemiological restrictions led to deferral of healthcare and influenced the variety of symptoms reported by patients suffering from Sudden Sensorineural Hearing Loss.</br></br> <b>Aim:</b> The aim of the study was to compare the duration of treatment implementation and symptoms reported by patients suffering from SSNHL before and during the COVID-19 pandemic.</br></br> <b>Material and methods:</b> Patients admitted to the Military Institute of Medicine - National Research Institute for SSNHL treatment were included in a survey conducted between 01.10.2021-31.12.2021. Questions on symptoms reported, chronic conditions, timeframe between first symptoms and implementation of pharmacotherapy, and hyperbaric oxygen therapy were included in the survey. The results were compared with data obtained by the Team between 01.2017-12.2019.</br></br> <b>Results:</b> 34 patients (19 females, 15 males) of the average age of 46.3 who participated in the survey indicated a significantly delayed implementation of pharmacotherapy and hyperbaric oxygen therapy in comparison to population from before the pandemic (12.08 vs. 5.41 [days]; 17.5 vs. 8.29 [days]). The survey also showed differences in the number of symptoms reported.</br></br> <b>Discussion:</b> The differences in time of implementation of SSNHL treatment could have been related to pandemic restrictions which contributed to longer queueing for health benefits and fear of contact with health service. Differences in symptomatology point towards SARS-CoV-2 as a pathogenetic factor of SSNHL.</br></br> <b>Conclusions:</b> The COVID-19 pandemic significantly influenced the treatment of Sudden Sensorineural Hearing Loss. The study demonstrated a diverse symptomatology of SSNHL before and during the pandemic.
<b>引言：</b> 新冠疫情对医疗体系构成了重大挑战。流行病学限制导致医疗服务延迟，并影响了突发性聋患者所报告的各种症状。</br></br> <b>目的：</b> 本研究旨在比较新冠疫情前后突发性聋患者的治疗实施时间和所报告的症状。</br></br> <b>材料与方法：</b> 我们纳入了于 2021 年 10 月 1 日至 12 月 31 日期间在军事医学研究所-国家突发性聋研究中心接受治疗的患者，并对其进行了一项调查。调查中包含了患者所报告的症状、慢性疾病、首次出现症状与实施药物治疗之间的时间间隔，以及高压氧治疗等问题。研究结果与团队在 2017 年 1 月至 2019 年 12 月期间获得的数据进行了比较。</br></br> <b>结果：</b> 34 名患者（19 名女性，15 名男性）参与了调查，平均年龄为 46.3 岁，与疫情前的人群相比，他们接受药物治疗和高压氧治疗的时间明显延迟（12.08 天比 5.41 天；17.5 天比 8.29 天）。调查还显示，他们所报告的症状数量也存在差异。</br></br> <b>讨论：</b> 突发性聋治疗实施时间的差异可能与疫情限制有关，这导致了对健康福利的排队时间延长，以及对接触卫生服务的恐惧。症状学方面的差异表明，SARS-CoV-2 可能是突发性聋的致病因素。</br></br> <b>结论：</b> 新冠疫情对突发性聋的治疗产生了重大影响。本研究表明，在疫情前后突发性聋的症状学表现存在差异。
